Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Part of paid clinical trials in Colleyville, Texas.
- Sponsor
- Surf Therapeutics
- Study ID
- NCT07293871
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Rheumatoid Arthritis (RA
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Active treatment — DEVICEDaily active ultrasound stimulation
- Sham (No Treatment) — DEVICEDaily sham ultrasound stimulation
Study Details
This two-stage, multicenter clinical trial is designed to evaluate the feasibility, safety, and preliminary efficacy of at-home ultrasound stimulation to activate immune-neuromodulation in patients with rheumatoid arthritis (RA) and at least moderate disease activity. The study will enroll up to 40 participants at up to 6 sites across 2 stages. The findings from this trial will directly inform the design and power calculations for a future pivotal trial by identifying an appropriate effect size and confirming protocol feasibility and safety for a daily home-use therapy.
Key Dates
- Start date
- Jan 31, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentDaily active stimulation for 8 weeks
- Sham Comparator: ControlDaily sham stimulation, for 8 weeks, which will look and feel the same as active stimulation, but with no ultrasound energy entering the body
Primary Outcome Measure
Change in high sensitivity CRP (hsCRP) [ Time Frame: 8 weeks ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 75034 | Dhiman Basu, MD (PRINCIPAL_INVESTIGATOR) |
| Precision Comprehensive Clinical Research Solutions | Irving | Texas | 75061 | Renuka Basavaraju, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Colleyville, TX
Related Studies
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.PHASE2 · Recruiting · Artiva Biotherapeutics, Inc. · Tuscaloosa, Alabama
- Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled TrialRecruiting · St. Lawrence Health System · Potsdam, New York
- Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-BeingRecruiting · Weill Medical College of Cornell University · New York, New York
- The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) StudyRecruiting · Brigham and Women's Hospital · Boston, Massachusetts